Biotech Values

[ghmm]

ITMN:

ITMN / ITMN-191: The Roche agreement was amended (per the 10-k filed yesterday)… Provisions for ITMN being bought out.

Can you elaborate? What were the old buyout provisions, if any, and what are the new buyout provisions? T.i.a.

I think your implication is right and I was probably hasty in my presumption. I did a quick look back
http://www.sec.gov/Archives/edgar/data/1087432/000095013407006990/f27471exv10w109.htm (3.2 Assignment/Change of Control.)
vs.
http://www.sec.gov/Archives/edgar/data/1087432/000119312509055456/dex1071.htm (item 5)
and to my (non lawyer) eyes maybe just provisions for amended terms of development of compounds and nothing changing pertaining to buyout.